168 related articles for article (PubMed ID: 37535198)
1. Periodontal and cardiovascular therapies modify specialized pro-resolving lipid mediator (sPRLM) (LPXA4, PD1, RvE1, RvD1, and MaR1)-mediated pathway: the first pilot clinical study.
Güvenç KK; Fentoğlu Ö; Calapoğlu M; Aksoy F; Orhan H
Clin Oral Investig; 2023 Sep; 27(9):5549-5558. PubMed ID: 37535198
[TBL] [Abstract][Full Text] [Related]
2. Salivary levels of specialized pro-resolving lipid mediators as indicators of periodontal health/disease status.
Tobón-Arroyave SI; Isaza-Guzmán DM; Gómez-Ortega J; Flórez-Alzate AA
J Clin Periodontol; 2019 Oct; 46(10):978-990. PubMed ID: 31339183
[TBL] [Abstract][Full Text] [Related]
3. Salivary levels of last generation specific pro-resolving lipid mediators (SPMs) (protectin and maresin) in patients with cardiovascular and periodontal disease: A case-control study.
Önal MA; Fentoğlu Ö; Aksoy F; Calapoğlu M; Varol E; Orhan H
J Periodontal Res; 2021 Jun; 56(3):606-615. PubMed ID: 33650687
[TBL] [Abstract][Full Text] [Related]
4. Sirtuin6 and Lipoxin A4 levels are decreased in severe periodontitis.
Cekici A; Sahinkaya S; Donmez MF; Turkmen E; Balci N; Toygar H
Clin Oral Investig; 2023 Dec; 27(12):7407-7415. PubMed ID: 37851128
[TBL] [Abstract][Full Text] [Related]
5. Maresin-1 and Resolvin E1 Promote Regenerative Properties of Periodontal Ligament Stem Cells Under Inflammatory Conditions.
Albuquerque-Souza E; Schulte F; Chen T; Hardt M; Hasturk H; Van Dyke TE; Holzhausen M; Kantarci A
Front Immunol; 2020; 11():585530. PubMed ID: 33101318
[TBL] [Abstract][Full Text] [Related]
6. Effect of specialized pro-resolving lipid mediators in the regulation of vascular tone and inflammation in human saphenous vein.
Celik Z; Ozen G; Sunar S; Turkyilmaz S; Turkyilmaz G; Kavala AA; Teskin O; Dogan BSU; Topal G
Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106786. PubMed ID: 37806440
[TBL] [Abstract][Full Text] [Related]
7. Adiposity associates with lower plasma resolvin E1 (Rve1): a population study.
Barden A; Shinde S; Beilin LJ; Phillips M; Adams L; Bollmann S; Mori TA
Int J Obes (Lond); 2024 May; 48(5):725-732. PubMed ID: 38347128
[TBL] [Abstract][Full Text] [Related]
8. Influence of Periodontal Disease on cardiovascular markers in Diabetes Mellitus patients.
Pedroso JF; Lotfollahi Z; Albattarni G; Arrruda Schulz M; Monteiro A; Sehnem AL; Gidlund MA; Figueiredo Neto AM; Jardini MAN
Sci Rep; 2019 Nov; 9(1):16138. PubMed ID: 31695086
[TBL] [Abstract][Full Text] [Related]
9. Resolution of post-lung transplant ischemia-reperfusion injury is modulated via Resolvin D1-FPR2 and Maresin 1-LGR6 signaling.
Leroy V; Cai J; Tu Z; McQuiston A; Sharma S; Emtiazjoo A; Atkinson C; Upchurch GR; Sharma AK
J Heart Lung Transplant; 2023 May; 42(5):562-574. PubMed ID: 36628837
[TBL] [Abstract][Full Text] [Related]
10. Pre-eclampsia is associated with reduced resolvin D1 and maresin 1 to leukotriene B4 ratios in the plasma.
Oliveira Perucci L; Pereira Santos TA; Campi Santos P; Ribeiro Teixeira LC; Nessralla Alpoim P; Braga Gomes K; Pires Sousa L; Sant'Ana Dusse LM; Talvani A
Am J Reprod Immunol; 2020 Feb; 83(2):e13206. PubMed ID: 31679164
[TBL] [Abstract][Full Text] [Related]
11. Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis.
Zhu M; Wang X; Hjorth E; Colas RA; Schroeder L; Granholm AC; Serhan CN; Schultzberg M
Mol Neurobiol; 2016 May; 53(4):2733-49. PubMed ID: 26650044
[TBL] [Abstract][Full Text] [Related]
12. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
[TBL] [Abstract][Full Text] [Related]
13. Assessment and correlation of the influence of non-surgical periodontal therapy on serum lipid profile and cytokines in patients with stage III periodontitis.
Kolte AP; Kolte RA; Bawankar PV; Bajaj VA
Int J Dent Hyg; 2023 May; 21(2):298-304. PubMed ID: 36300675
[TBL] [Abstract][Full Text] [Related]
14. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.
Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR
Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798
[TBL] [Abstract][Full Text] [Related]
15. Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis.
Hasturk H; Abdallah R; Kantarci A; Nguyen D; Giordano N; Hamilton J; Van Dyke TE
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1123-33. PubMed ID: 25792445
[TBL] [Abstract][Full Text] [Related]
16. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Dental Status and Systemic Lipid Profile and Inflammatory Mediators in Patients After Myocardial Infarction.
Górski B; Nargiełło E; Opolski G; Ganowicz E; Górska R
Adv Clin Exp Med; 2016; 25(4):625-30. PubMed ID: 27629835
[TBL] [Abstract][Full Text] [Related]
18. Impact of non-surgical periodontal therapy on saliva and serum levels of markers of oxidative stress.
Önder C; Kurgan Ş; Altıngöz SM; Bağış N; Uyanık M; Serdar MA; Kantarcı A; Günhan M
Clin Oral Investig; 2017 Jul; 21(6):1961-1969. PubMed ID: 27807715
[TBL] [Abstract][Full Text] [Related]
19. Resolvin D1 (RvD1) and maresin 1 (Mar1) contribute to human macrophage control of M. tuberculosis infection while resolving inflammation.
Ruiz A; Sarabia C; Torres M; Juárez E
Int Immunopharmacol; 2019 Sep; 74():105694. PubMed ID: 31226532
[TBL] [Abstract][Full Text] [Related]
20. Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation.
Hasturk H; Schulte F; Martins M; Sherzai H; Floros C; Cugini M; Chiu CJ; Hardt M; Van Dyke T
Front Immunol; 2021; 12():704163. PubMed ID: 34589083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
